Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
A clinical review of losartan safety signals reported through the FDA Adverse Event Reporting System (FAERS), including hyperkalemia, acute kidney injury, and nitrosamine impurity recalls.
Read clinical reviewFull FDA approval history of losartan (Cozaar), from its 1995 original approval through generic entry, pediatric labeling, LIFE trial supplemental data, and recall events.
Read clinical reviewA clinical review of losartan's patent disputes, FDA approval timeline, NDMA recall actions, and the regulatory events that shaped ARB prescribing in the United States.
Read clinical reviewA detailed comparison of how the European Medicines Agency and U.S. Food and Drug Administration regulate losartan, including approval history, labeling differences, and post-market safety oversight.
Read clinical review